Quarterly report pursuant to Section 13 or 15(d)

Licensing and Other Arrangements - Rezolute - Second and Third Amendments (Details)

v3.20.2
Licensing and Other Arrangements - Rezolute - Second and Third Amendments (Details)
$ in Thousands
1 Months Ended 2 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2020
USD ($)
installment
Sep. 30, 2019
USD ($)
Jan. 30, 2019
USD ($)
Jan. 07, 2019
USD ($)
item
Apr. 03, 2018
USD ($)
Dec. 06, 2017
shares
Mar. 31, 2019
USD ($)
Mar. 31, 2018
USD ($)
Aug. 31, 2019
USD ($)
item
Jun. 30, 2020
USD ($)
Mar. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Sep. 30, 2019
USD ($)
Jun. 30, 2019
USD ($)
Mar. 31, 2019
USD ($)
Jun. 30, 2020
USD ($)
Jun. 30, 2019
USD ($)
Dec. 31, 2020
shares
Dec. 31, 2019
USD ($)
shares
Dec. 31, 2018
USD ($)
Licensing and other arrangements                                        
Revenue from contracts with customers                   $ 53       $ 625   $ 553 $ 8,651      
Provision for bad debt                               1,409        
Bad debt allowance                   1,409           1,409        
Rezolute | License Agreement and Common Stock Purchase Agreement                                        
Licensing and other arrangements                                        
Amount of Rezolute's common stock eligible to receive       $ 8,500       $ 8,500                        
Number of future cash payments upon closing of the qualified financing | item       5                                
Future cash payments upon closing of the qualified financing       $ 8,500                     $ 8,500          
Percentage of net proceeds of each future financing upon closing of the qualified financing       15.00%                                
Gross proceeds received by third party from preferred stock financing     $ 25,000                                  
Consideration received following qualified financing event     5,500                                  
Reimbursable technology transfer expense received     $ 300   $ 300                              
Revenue from contracts with customers             $ 2,500           $ 6,000             $ 1,800
Doubtful revenue reversal of future cash payments             $ 2,500   $ 3,600           $ 2,500          
Number of common stock financing events | item                 2                      
Early payment of unrecognized future cash payments                 $ 3,400                      
Unrecognized future cash payments                           $ 6,000     $ 6,000      
Future cash payments received   $ 1,500               400 $ 400 $ 1,000 $ 4,900              
Upfront consideration to incremental discount for future payment         0                              
Outstanding receivable                   400           400        
Contract assets                   0   0       0     $ 0  
Contract liabilities                   0   0       0     0  
Capitalized contract costs                   0   $ 0       0     $ 0  
Rezolute | License Agreement and Common Stock Purchase Agreement | Maximum                                        
Licensing and other arrangements                                        
Future cash payments of revenue recognized       $ 8,500                                
Rezolute | License Agreement                                        
Licensing and other arrangements                                        
Reimbursable technology transfer expense received         $ 300                              
Revenue from contracts with customers                   0           0        
Future cash payments of revenue recognized $ 2,600                                      
Number of quarterly payments | installment 7                                      
Payment period following closing of Qualified Financing 15 days                                      
Provision for bad debt                     $ 1,400                  
Bad debt allowance                   $ 1,400           $ 1,400        
Rezolute | Common Stock Purchase Agreement                                        
Licensing and other arrangements                                        
Number of Rezolute's shares Company has right and option to sell if Rezolute does not list common stock shares on national exchange | shares           5,000,000                         5,000,000  
Rezolute | Common Stock Purchase Agreement | Forecast | Maximum                                        
Licensing and other arrangements                                        
Number of Rezolute's shares Company has right and option to sell if Rezolute does not list common stock shares on national exchange | shares                                   2,500,000